480 related articles for article (PubMed ID: 31832993)
1. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM
Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993
[TBL] [Abstract][Full Text] [Related]
2. Androgens in women: Hormone-modulating therapies for skin disease.
Azarchi S; Bienenfeld A; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
J Am Acad Dermatol; 2019 Jun; 80(6):1509-1521. PubMed ID: 30312645
[TBL] [Abstract][Full Text] [Related]
3. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
4. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
Krausz A; Friedman AJ
J Drugs Dermatol; 2013 Nov; 12(11):1297-300. PubMed ID: 24358489
[No Abstract] [Full Text] [Related]
7. Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris.
Coneac A; Muresan A; Orasan MS
Clujul Med; 2014; 87(4):226-34. PubMed ID: 26528029
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
Khandpur S; Suman M; Reddy BS
J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
[TBL] [Abstract][Full Text] [Related]
9. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne.
Peterson H; Kircik L; Armstrong AW
J Drugs Dermatol; 2023 Jun; 22(6):SF350992s7-SF350992s14. PubMed ID: 37276168
[TBL] [Abstract][Full Text] [Related]
10. Androgenetic Alopecia: An Update of Treatment Options.
Kelly Y; Blanco A; Tosti A
Drugs; 2016 Sep; 76(14):1349-64. PubMed ID: 27554257
[TBL] [Abstract][Full Text] [Related]
11. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Fields JR; Vonu PM; Monir RL; Schoch JJ
Dermatol Ther; 2020 Jan; 33(1):e13202. PubMed ID: 31858672
[TBL] [Abstract][Full Text] [Related]
12. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
13. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
Battmann T; Bonfils A; Branche C; Humbert J; Goubet F; Teutsch G; Philibert D
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):55-60. PubMed ID: 8136306
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
[TBL] [Abstract][Full Text] [Related]
15. Clascoterone: First Approval.
Dhillon S
Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710
[TBL] [Abstract][Full Text] [Related]
16. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
Münster U; Nakamura C; Haberland A; Jores K; Mehnert W; Rummel S; Schaller M; Korting HC; Zouboulis ChC; Blume-Peytavi U; Schäfer-Korting M
Pharmazie; 2005 Jan; 60(1):8-12. PubMed ID: 15700772
[TBL] [Abstract][Full Text] [Related]
17. The antiandrogens. When and how they should be used.
Sawaya ME; Hordinsky MK
Dermatol Clin; 1993 Jan; 11(1):65-72. PubMed ID: 8435919
[TBL] [Abstract][Full Text] [Related]
18. Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro.
Rosette C; Rosette N; Mazzetti A; Moro L; Gerloni M
J Drugs Dermatol; 2019 Feb; 18(2):197-201. PubMed ID: 30811143
[TBL] [Abstract][Full Text] [Related]
19. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
[TBL] [Abstract][Full Text] [Related]
20. Androgenetic Alopecia: Therapy Update.
Devjani S; Ezemma O; Kelley KJ; Stratton E; Senna M
Drugs; 2023 Jun; 83(8):701-715. PubMed ID: 37166619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
